Top Drug Lawsuits
|Biomet Hip Implant Lawsuits Consolidated in Indiana Federal Court|
- Wednesday, 10 October 2012 13:50
Biomet Hip Implant Lawsuits Consolidated in Indiana Federal Court
By Andrea Gressman
Biomet was not in favor of the centralization. The metal hip implant manufacturer felt that centralization was unwarranted due to the claim that the Biomet hip implant lawsuits contained issues specific to individual plaintiffs. They also had concerns about the fact that their metal on metal hip implants were not recalled, which differed from the recalled hip implants in the MDL involving DePuy Orthopaedics' ASR hip implants, according to the Order of Transfer.
Biomet continued their argument, stating that they have settled Biomet hip implant lawsuits involving the M2a Magnum before, and did so in an efficient way. They also argued that these metal hip implants had fewer problems than similar products. The panel of judges did agree that these arguments were valid. However, they did not carry enough weight to decide against consolidation.
Issues Leading to Biomet Hip Implant Lawsuit Consolidation
The panel found that each Biomet hip implant lawsuit involving the M2a Magnum hip implant contained consistent issues regarding the possibility of a common flaw leading to the plaintiff’s alleged injuries and side effects. Additionally, the panel noted that even though almost all injury litigation does contain issues specific to certain cases and plaintiffs, these differences have not slowed down or halted centralization in the past. The reason for consolidating lawsuits, such as the Biomet hip implant lawsuits, is to expedite the resolution of claims efficiently and to reduce the amount of resources provided of all parties involved.
It is a common feeling among many Biomet lawsuit attorneys that the consolidation of these M2a Magnum hip implant lawsuits represents a huge step forward in the growing number of Biomet lawsuits involving metal-on-metal hip implants. Based upon hundreds of plaintiffs who suffered injuries from metal-on-metal hip implants from numerous hip replacement manufacturers, it has been found that the plaintiffs are happy that another MDL has been established to efficiently facilitate the resolution of the plaintiff’s Biomet M2a Magnum lawsuits.
Biomet M2a Magnum Lawsuits Claim Design is Flawed Resulting in Numerous Side Effects
The Biomet M2a Magnum lawsuits claim the hip implant’s metal-on-metal design is flawed, resulting in potential metallosis and premature hip implant failure -- believed to be the result of metal ions generated at a high level from the hip implant’s metal parts. The Biomet M2a Magnum metal hip implant is only one of many devices associated with these side effects. A July 12, 2012 article by Fox News states that there are other manufacturers of meal-on-metal hip implant devices -- including DePuy, Zimmer Holdings, and Wright Medical – that have similar issues regarding serious side effects of their metal hip implant devices.
A number of Biomet hip implant attorneys continue their investigation of Biomet hip implant side effects on behalf of potential plaintiffs who experienced adverse side effects of a metal-on-metal hip implant such as the M2a Magnum. Please visit the DePuy, Biomet, Wright Medical Technology & Zimmer, Metal on Metal Hip Implant Class Action Lawsuit Investigation page. Additional information, as well as a free legal consultation is available. All you have to do is provide your information and a Biomet hip implant lawyer will be happy to go over the hip implant side effects you may be experiencing, including pain, swelling, dislocated hip, cancer, loss of bone strength, bone fractures, tissue death, non-cancerous tumors, psedotumors, Cobalt poisoning, metallosis, premature failure, and any other side effect you may have experienced.
Updated October 10th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
Last Updated on Thursday, 27 December 2012 11:09